Annual Revenue
$58.49 M
+$14.61 M+33.30%
December 31, 2024
Summary
- As of March 13, 2025, RXRX annual revenue is $58.49 million, with the most recent change of +$14.61 million (+33.30%) on December 31, 2024.
- During the last 3 years, RXRX annual revenue has risen by +$48.49 million (+484.88%).
- RXRX annual revenue is now at all-time high.
Performance
RXRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$4.51 M
-$21.57 M-82.70%
December 31, 2024
Summary
- As of March 13, 2025, RXRX quarterly revenue is $4.51 million, with the most recent change of -$21.57 million (-82.70%) on December 31, 2024.
- Over the past year, RXRX quarterly revenue has dropped by -$21.57 million (-82.70%).
- RXRX quarterly revenue is now -82.70% below its all-time high of $26.08 million, reached on September 30, 2024.
Performance
RXRX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$58.49 M
-$6.11 M-9.46%
December 31, 2024
Summary
- As of March 13, 2025, RXRX TTM revenue is $58.49 million, with the most recent change of -$6.11 million (-9.46%) on December 31, 2024.
- Over the past year, RXRX TTM revenue has dropped by -$6.11 million (-9.46%).
- RXRX TTM revenue is now -9.46% below its all-time high of $64.60 million, reached on September 30, 2024.
Performance
RXRX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
RXRX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +33.3% | -82.7% | -9.5% |
| 3 y3 years | +484.9% | -82.7% | -9.5% |
| 5 y5 years | +3318.3% | -82.7% | -9.5% |
RXRX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +484.9% | -82.7% | +80.4% | -9.5% | +484.9% |
| 5 y | 5-year | at high | +3318.3% | -82.7% | +423.3% | -9.5% | +6685.1% |
| alltime | all time | at high | +3318.3% | -82.7% | +423.3% | -9.5% | +6685.1% |
Recursion Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $58.49 M(+33.3%) | $4.51 M(-82.7%) | $58.49 M(-9.5%) |
| Sep 2024 | - | $26.08 M(+81.1%) | $64.60 M(+32.9%) |
| Jun 2024 | - | $14.40 M(+6.8%) | $48.62 M(+7.5%) |
| Mar 2024 | - | $13.49 M(+27.0%) | $45.23 M(+3.1%) |
| Dec 2023 | $43.88 M(+10.6%) | $10.62 M(+5.2%) | $43.88 M(-6.5%) |
| Sep 2023 | - | $10.10 M(-8.3%) | $46.93 M(-5.9%) |
| Jun 2023 | - | $11.02 M(-9.2%) | $49.88 M(+7.2%) |
| Mar 2023 | - | $12.13 M(-11.3%) | $46.52 M(+17.2%) |
| Dec 2022 | $39.68 M | $13.68 M(+4.8%) | $39.68 M(+39.2%) |
| Sep 2022 | - | $13.05 M(+70.6%) | $28.50 M(+58.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $7.65 M(+44.4%) | $17.95 M(+40.3%) |
| Mar 2022 | - | $5.30 M(+112.0%) | $12.80 M(+28.0%) |
| Dec 2021 | $10.00 M(+193.0%) | $2.50 M(0.0%) | $10.00 M(-0.5%) |
| Sep 2021 | - | $2.50 M(0.0%) | $10.05 M(+19.5%) |
| Jun 2021 | - | $2.50 M(0.0%) | $8.41 M(+42.3%) |
| Mar 2021 | - | $2.50 M(-2.0%) | $5.91 M(+73.2%) |
| Dec 2020 | $3.41 M(+99.5%) | - | - |
| Dec 2020 | - | $2.55 M(+195.9%) | $3.41 M(+295.9%) |
| Sep 2020 | - | $862.00 K | $862.00 K |
| Dec 2019 | $1.71 M | - | - |
FAQ
- What is Recursion Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual revenue year-on-year change?
- What is Recursion Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly revenue year-on-year change?
- What is Recursion Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals TTM revenue year-on-year change?
What is Recursion Pharmaceuticals annual revenue?
The current annual revenue of RXRX is $58.49 M
What is the all time high annual revenue for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual revenue is $58.49 M
What is Recursion Pharmaceuticals annual revenue year-on-year change?
Over the past year, RXRX annual revenue has changed by +$14.61 M (+33.30%)
What is Recursion Pharmaceuticals quarterly revenue?
The current quarterly revenue of RXRX is $4.51 M
What is the all time high quarterly revenue for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly revenue is $26.08 M
What is Recursion Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, RXRX quarterly revenue has changed by -$21.57 M (-82.70%)
What is Recursion Pharmaceuticals TTM revenue?
The current TTM revenue of RXRX is $58.49 M
What is the all time high TTM revenue for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high TTM revenue is $64.60 M
What is Recursion Pharmaceuticals TTM revenue year-on-year change?
Over the past year, RXRX TTM revenue has changed by -$6.11 M (-9.46%)